EP2869841

Nýjar næmiörvunaráætlanir sem innihalda ónæmisvaldandi fjölpeptíð kóðuð af fjölkirnum

  • Status:
    EP Einkaleyfi ógilt eftir andmæli
  • EP appl. date:
    5.7.2013
  • EP published:
    25.8.2021
  • EP application number:
    13734111.1
  • Max expiry date:
    4.7.2033
  • Expiry date:
    4.7.2025
  • Title:
    NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES

Timeline

Today
5.7.2013EP application
25.8.2021EP Publication
2.11.2021Translation submitted
15.12.2021Registration published
4.7.2025Expires

Owner

  • Name:
    GlaxoSmithKline Biologicals SA
  • Address:
    Rue de l'Institut 89, 1330 Rixensart, BE

Inventor

  • Name:
    NICOSIA, Alfredo
  • Address:
    80123 Naples, IT
  • Name:
    CORTESE, Ricardo
  • Address:
    1330 Rixensart, BE
  • Name:
    VITELLI, Alessandra
  • Address:
    00152 Rome, IT

Agent

  • Name:
    Zacco Denmark A/S
  • Address:
    Arne Jacobsens Allé 15, DK

Priority

  • Number:
    PCT/EP2012/063196
  • Date:
    5.7.2012
  • Country:
    WO

Classification

  • Categories:
    A61K 39/155, C12N 15/861, C12N 15/863, C07K 16/44

Annual fees

Number

Paid

Expires

Payer

Number: 10

Paid: 21.6.2022

Expires: 4.7.2023

Payer: Patice ehf.

Number: 11

Paid: 22.6.2023

Expires: 4.7.2024

Payer: Árnason Faktor ehf.

Number: 12

Paid: 19.6.2024

Expires: 4.7.2025

Payer: Árnason Faktor ehf.

Upload documents